Walleye Capital’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-141,127
| Closed | -$871K | – | 1950 |
|
|
2024
Q4 | $871K | Buy |
141,127
+71,127
| +102% | +$439K | ﹤0.01% | 977 |
|
|
2024
Q3 | $377K | Buy |
70,000
+9,788
| +16% | +$52.7K | ﹤0.01% | 1462 |
|
|
2024
Q2 | $202K | Sell |
60,212
-134,339
| -69% | -$450K | ﹤0.01% | 1857 |
|
|
2024
Q1 | $784K | Sell |
194,551
-167,836
| -46% | -$676K | ﹤0.01% | 1168 |
|
|
2023
Q4 | $960K | Sell |
362,387
-11,126
| -3% | -$29.5K | ﹤0.01% | 913 |
|
|
2023
Q3 | $881K | Buy |
373,513
+362,375
| +3,254% | +$855K | ﹤0.01% | 928 |
|
|
2023
Q2 | $70.2K | Buy |
+11,138
| New | +$70.2K | ﹤0.01% | 1526 |
|
|
2023
Q1 | – | Sell |
-10,703
| Closed | -$110K | – | 2286 |
|
|
2022
Q4 | $110K | Buy |
+10,703
| New | +$110K | ﹤0.01% | 1519 |
|